[Atypical subtrochanteric femur fracture under alendronate therapy in spite of an intramedullar implant].
There are a number of case reports about women undergoing long-term bisphosphonate therapy who have suffered an atypical subtrochanteric or femoral shaft fracture due to an inadequate trauma.The present case reports on a patient who underwent a subtrochanteric femur fracture with the inserted AO femur interlocking nail.
Orthopädische Klinik, Herzogin Elisabeth Hospital, Leipziger Straße 24, 38124, Braunschweig, Deutschland. h.sobotta@heh-bs.de.
H-P
HP
Sobotta
Klinik für Unfallchirurgie und Orthopädische Chirurgie, Städtisches Klinikum Braunschweig, Braunschweig, Deutschland.
T
T
Gösling
D000369:Aged, 80 and over; D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005594:Fracture Fixation, Intramedullary / Q000295:instrumentation*; D006620:Hip Fractures / Q000139:chemically induced* / Q000517:prevention & control / Q000601:surgery*; D006801:Humans; D017211:Treatment Failure; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D019386:Alendronate
Atypical femoral fracture; Implant fracture; Osteoporosis; Subtrochanteric fracture; Therapy with alendronate